Eighty-eight long-billed dowitchers, Limnodromus scolopaceus, were examined for helminth parasites, 62 from Texas and 26 from Mexico. In total, 3,558 helminth parasites were obtained from this host, 2,273 from Texas birds and 1,285 from birds from Mexico. The component communities consisted of 22 species of helminths in Texas, and 19 in Mexico. Of a total of 26 helminth species recorded from the 2 localities, 15 were common to both, 7 found only in Texas, and 4 only in Mexico. Fifty-nine of 62 Texas birds and 25 of 26 birds from Mexico were infected. The most prevalent helminth for Texas was the cestode Shipleya inermis. The cestode Aploparaksis retroversa was the most abundant, accounting for 37% of the total abundance, and was second highest in prevalence. Five species of cestodes, A. retroversa, Aploparaksis diagonalis, Aploparaksis occidentalis, Aploparaksis rissae, and Shipleya inermis accounted for 79% of total abundance. In the sample from Mexico, S. inermis was also highest in prevalence, followed by the nematode Hystrichis tricolor. The cestode A. retroversa was highest in abundance at 50% of the total, and was third highest in prevalence. Mean species richness, diversity, and evenness were similar among the component communities of Texas and Mexico. A predictable suite of aploparaksid cestodes, together with the cestode S. inermis, constituted 79%, and 61%, of total abundance for the component communities of Texas and Mexico, respectively, and were present in all component communities for locality, season, and year. The cestodes, A. retroversa and S. inermis, were the dominant species in all component communities. Differences among component communities and low similarities for all other comparisons were largely caused by less predictable suites of helminth species. A checklist of helminth parasites reported for long-billed dowitchers is included.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 96 • No. 6